ArticleBlood cancer journal2026

Effect of anemia developed after ruxolitinib initiation on adverse outcomes in patients with myelofibrosis: a nationwide cohort study.

Minjeong Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.